BioSpace News Archive

Nouscom – IND for NOUS-209, an ‘off-the-shelf’ Neoantigen Cancer Vaccine, Cleared by FDA to Commence Clinical Development in MSI Solid Tumors

Nouscom, an immuno-oncology company developing off-the-shelf and personalized cancer neoantigen vaccines, announced today that its Investigational New Drug (IND) application for the first clinical trial of its lead candidate NOUS-209 has been cleared by the US Food and Drug Administration (FDA).

June 5, 2019
·
2 min read
Drug Development

BRACAnalysis CDx® Companion Diagnostic Test Identifies Patients with Metastatic Pancreatic Cancer Who Benefited from Treatment with Lynparza® (olaparib)

Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in personalized medicine,today announced that its BRACAnalysis CDx® companion diagnostic test effectively identified patients with metastatic pancreatic cancer who benefitted from treatment with Lynparza® (olaparib) in the Phase III POLO study.

June 5, 2019
·
9 min read
Kymab Presents Poster Detailing Adaptive Phase 1/2 Clinical Trial for its KY1044 Anti-ICOS Program at ASCO 2019 Annual Meeting

Kymab, a clinical-stage biopharmaceutical company developing antibody-based therapeutics, todayannounced a poster presentation detailing updates on the ongoing clinical trial of the company’s anti-ICOS program KY1044 at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting.

June 5, 2019
·
4 min read
Essity Sets Additional Sustainability Targets for Packaging

The global hygiene and health company Essity has set additional packaging targets aimed at reducing its environmental footprint.

June 5, 2019
·
1 min read
Business

QIAGEN and DiaSorin collaborate on novel QuantiFERON-based test with breakthrough potential for earlier detection of Lyme disease

QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) and DiaSorin (FTSE MIB: DIA) today announced the expansion of their QuantiFERON collaboration to develop an ultra-sensitive diagnostic test for Lyme disease, which is expected to address a significant unmet medical need.

June 5, 2019
·
2 min read
Otsuka Chemical Succeeded Part of the Cefixime Business from Astellas Pharma

Otsuka Chemical Co., Ltd. announces that it has succeeded part of the Cefixime business from Astellas Pharma, Inc..

June 5, 2019
·
1 min read
BioForest

StillCanna Enters into a Strategic Relationship with CBD Logistics Expert for Secure Transportation of its Products Internationally

StillCanna Inc. is pleased to announce it has entered a strategic relationship with Sarah Yetman, an expert in the international transportation of industrial hemp and CBD.

June 5, 2019
·
4 min read
BioMidwest

3M to Sell its Gas and Flame Detection Business

3M announced it has received a binding offer from Teledyne Technologies Incorporated, to purchase 3M’s gas and flame detection business for $230 million, subject to closing and other adjustments.

June 5, 2019
·
4 min read
Job Trends

Two New Studies Show That Texas Districts Using STEMscopes Outperform Other Districts on State Science Assessments

STEMscopes districts have higher passing rates on grade 5 science and Biology End-of-Course STAAR assessments than non-STEMscopes districts

June 5, 2019
·
2 min read
Business

OneOncology Expands Executive Leadership Team

Appointments Bring Unrivaled Experience to Clinical, Technological and Financial Operations at OneOncology

June 5, 2019
·
2 min read